日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clonal driver neoantigen loss under EGFR TKI and immune selection pressures

EGFR TKI 和免疫选择压力下的克隆驱动新抗原丢失

Maise Al Bakir # ,James L Reading # ,Samuel Gamble ,Rachel Rosenthal ,Imran Uddin ,Andrew Rowan ,Joanna Przewrocka ,Amber Rogers ,Yien Ning Sophia Wong ,Amalie K Bentzen ,Selvaraju Veeriah ,Sophia Ward ,Aaron T Garnett ,Paula Kalavakur ,Carlos Martínez-Ruiz ,Clare Puttick ,Ariana Huebner ,Daniel E Cook ,David A Moore ,Chris Abbosh ,Crispin T Hiley ,Cristina Naceur-Lombardelli ,Thomas B K Watkins ,Marina Petkovic ,Roland F Schwarz ,Felipe Gálvez-Cancino ,Kevin Litchfield ,Peter Meldgaard ,Boe Sandahl Sorensen ,Line Bille Madsen ,Dirk Jäger ,Martin D Forster ,Tobias Arkenau ,Clara Domingo-Vila ,Timothy I M Tree ,Mohammad Kadivar ,Sine Reker Hadrup ,Benny Chain ,Sergio A Quezada ,Nicholas McGranahan ,Charles Swanton

Cell-free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients

无细胞染色质免疫沉淀可确定肺癌患者的肿瘤基因表达

Christoffer Trier Maansson, Peter Meldgaard, Magnus Stougaard, Anders Lade Nielsen, Boe Sandahl Sorensen

Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer

血液肿瘤突变负荷和循环肿瘤 DNA 的动态变化可预测晚期非小细胞肺癌对派姆单抗治疗的反应

Simone Stensgaard, Astrid Thomsen, Sofie Helstrup, Peter Meldgaard, Boe S Sorensen

EGFR transcription in non-small-cell lung cancer tumours can be revealed in ctDNA by cell-free chromatin immunoprecipitation (cfChIP)

非小细胞肺癌肿瘤中的 EGFR 转录可通过无细胞染色质免疫沉淀 (cfChIP) 在 ctDNA 中揭示

Christoffer Trier Månsson, Johan Vad-Nielsen, Peter Meldgaard, Anders Lade Nielsen, Boe Sandahl Sorensen

cGAS-STING pathway expression as a prognostic tool in NSCLC

cGAS-STING 通路表达作为 NSCLC 的预后工具

Kristine Raaby Gammelgaard, Birgitte Sandfeld-Paulsen, Stine Høvring Godsk, Christina Demuth, Peter Meldgaard, Boe Sandahl Sorensen, Martin Roelsgaard Jakobsen

A method for treatment monitoring using circulating tumour DNA in cancer patients without targetable mutations

一种利用循环肿瘤 DNA 对无可靶向突变的癌症患者进行治疗监测的方法

Christina Demuth, Anne Winther-Larsen, Anne Tranberg Madsen, Peter Meldgaard, Boe Sandahl Sorensen

Dasatinib and Doxorubicin Treatment of Sarcoma Initiating Cells: A Possible New Treatment Strategy

达沙替尼和阿霉素治疗肉瘤起始细胞:一种可能的新治疗策略

Ninna Aggerholm-Pedersen, Christina Demuth, Akmal Safwat, Peter Meldgaard, Moustapha Kassem, Boe Sandahl Sorensen